| Financial Year |
March 31 2023 |
| Monetary Funds |
5,937,985,463.70 |
| Held-for-trading Financial Assets |
4,350,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
770,865,862.77 |
| Advances to Suppliers |
16,408,554.61 |
| Other Receivables |
89,180,310.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,620,256.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
361,243,170.61 |
| Total Current Assets |
11,806,085,081.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,089,905,052.20 |
| Investment Properties |
-- |
| Fixed Assetes |
5,191,303,255.37 |
| Under-construction Projects |
339,295,897.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
205,908,198.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
152,093.19 |
| Deferred Income Tax Assets |
26,250,801.69 |
| Other Non-Current Assets |
940,670,167.73 |
| Sub-Total of Non-Current Assets |
9,900,660,004.24 |
| Total Assets |
21,706,745,085.92 |
| Short-Term Loans |
300,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,072,235,304.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,993,033.78 |
| Taxes Payable |
307,185,150.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
323,132,254.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,394,654,151.01 |
| Other Current Liabilities |
23,906,108.94 |
| Sub-Total of Current Liabilities |
5,808,184,064.62 |
| Long-term Loans |
3,864,014,109.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
596,928,728.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
301,254,737.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,959,031,691.97 |
| Total Liabilities |
11,767,215,756.59 |
| Paid-In Capital(Or Share Stock) |
1,418,961,556.00 |
| Capital Surplus |
4,025,775,898.19 |
| Surplus Reserve |
709,480,778.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,760,307,771.89 |
| Minority Stockholder's Interest |
33,593,899.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,905,935,429.50 |
| Owner's Equity（Stockholder's Equity） |
9,939,529,329.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,706,745,085.92 |
